Research on automatic evaluative responses to faces varying in emotional expression and ethnicity has yielded conflicting results. Some paradigms, like the Approach/Avoidance task, demonstrated interactive evaluation. In contrast, recent studies using the Evaluative Priming Task (EPT) yielded independent effects of expression and ethnicity. One key difference between these paradigms is the task relevance of the faces. In the EPT faces served solely as primes without direct relevance to the task. To examine whether increased task relevance could engender interactive processing in the EPT, we utilized a modified version of the "bona fide pipeline" EPT. In this adaptation, participants categorized the valence of target words succeeding prime faces followed by probe faces. Participants then judged whether the prime and probe faces depicted the same person, thereby adding task relevance to the prime faces. Experiment 1 revealed independent priming effects of emotion and ethnicity. Since error data and inverse efficiency scores provided evidence for an interactive evaluation, we replicated Experiment 1 using a sequential Bayes testing strategy. Experiment 2 confirmed that the effects of emotion and ethnicity remain independent, indicating that increased task relevance did not yield the integrated processing of emotion and ethnicity as initially hypothesized.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1027/1618-3169/a000628 | DOI Listing |
JAMA Netw Open
January 2025
Men's Health Inequities Research Lab, Milwaukee, Wisconsin.
Importance: Research indicates that social drivers of health are associated with cancer screening adherence, although the exact magnitude of these associations remains unclear.
Objective: To investigate the associations between individual-level social risks and nonadherence to guideline-recommended cancer screenings.
Design, Setting, And Participants: This cross-sectional study used 2022 Behavioral Risk Factor Surveillance System data from 39 US states and Washington, DC.
Alzheimers Dement
December 2024
Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Background: Aging is a time-dependent deterioration of physiological functions that occurs in both humans and animals. Within the brain, aging cells gradually become dysfunctional through a complex interplay of intrinsic and extrinsic factors, ultimately leading to behavioral deficits and enhanced risk of neurodegenerative diseases such as Alzheimer's disease (AD). The characteristics of normal aging are distinct from those associated with age-related diseases and it is important to understand the processes that contribute to this pathological divergence.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Texas A&M University, College Station, TX, USA.
Background: Older females, particularly susceptible to Alzheimer's disease (AD), may be affected by hormonal fluctuation during life. We aim to investigate the relationship between changes in brain volume and sex steroid hormones over time. We hypothesize that levels of sex hormones (17ß-estradiol, progesterone, and testosterone) relate to changes in brain volume, especially in the hippocampus (HPC) and cerebellum (CB).
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of California, San Francisco, San Francisco, CA, USA.
Background: Autosomal dominant progranulin (GRN) mutations are a common genetic cause of frontotemporal lobar degeneration. Though clinical trials for GRN-related therapies are underway, there is an unmet need for biomarkers that can predict symptom onset and track disease progression. We previously showed that presymptomatic GRN carriers exhibit thalamocortical hyperconnectivity that increases with age when they are presumably closer to symptom onset.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, United Kingdom.
Background: Frontotemporal dementia (FTD) and Progressive Supranuclear Palsy (PSP) have distinct molecular pathologies, with Tau and TDP43 aggregation, and distinct patterns of regional brain atrophy. However, they share the synaptotoxicity of protein aggregation, and neurotransmitter loss (including GABA), which contribute to clinical and neurophysiological similarities. Defining the relationships between synaptic loss, network physiology and cognition builds bridges between preclinical and clinical studies, and facilitates early phase trials.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!